Concepts (176)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Precursors | 3 | 2024 | 74 | 1.580 |
Why?
|
| Sequence Analysis, RNA | 9 | 2024 | 155 | 1.550 |
Why?
|
| RNA, Messenger | 11 | 2024 | 1470 | 1.430 |
Why?
|
| RNA Splicing | 4 | 2025 | 160 | 1.360 |
Why?
|
| Gene Expression Regulation | 12 | 2022 | 1540 | 1.210 |
Why?
|
| Quantitative Trait Loci | 9 | 2017 | 71 | 1.190 |
Why?
|
| Alternative Splicing | 4 | 2022 | 120 | 1.080 |
Why?
|
| DNA Methylation | 5 | 2015 | 273 | 1.010 |
Why?
|
| Transcription, Genetic | 6 | 2024 | 848 | 0.980 |
Why?
|
| RNA, Long Noncoding | 2 | 2022 | 152 | 0.850 |
Why?
|
| Introns | 4 | 2022 | 106 | 0.840 |
Why?
|
| Transcriptome | 2 | 2022 | 334 | 0.750 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2018 | 87 | 0.720 |
Why?
|
| Islets of Langerhans | 1 | 2022 | 267 | 0.700 |
Why?
|
| Gene Expression | 3 | 2012 | 807 | 0.690 |
Why?
|
| Genetic Variation | 6 | 2017 | 367 | 0.680 |
Why?
|
| Chromatin | 6 | 2022 | 597 | 0.650 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 3 | 2014 | 96 | 0.560 |
Why?
|
| RNA Stability | 3 | 2022 | 94 | 0.550 |
Why?
|
| Genome, Human | 6 | 2015 | 219 | 0.520 |
Why?
|
| Pan troglodytes | 3 | 2014 | 35 | 0.510 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 675 | 0.490 |
Why?
|
| Exons | 5 | 2024 | 193 | 0.480 |
Why?
|
| Drosophila | 1 | 2017 | 420 | 0.470 |
Why?
|
| Models, Genetic | 2 | 2016 | 253 | 0.460 |
Why?
|
| Drosophila melanogaster | 1 | 2018 | 482 | 0.460 |
Why?
|
| Transcription Initiation Site | 2 | 2024 | 48 | 0.370 |
Why?
|
| Genome-Wide Association Study | 6 | 2015 | 324 | 0.330 |
Why?
|
| Computational Biology | 3 | 2024 | 329 | 0.300 |
Why?
|
| Humans | 32 | 2024 | 59799 | 0.290 |
Why?
|
| Environment | 2 | 2018 | 125 | 0.280 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2024 | 259 | 0.270 |
Why?
|
| Gene Expression Profiling | 8 | 2018 | 708 | 0.270 |
Why?
|
| Models, Theoretical | 2 | 2018 | 258 | 0.260 |
Why?
|
| Polyadenylation | 2 | 2024 | 44 | 0.250 |
Why?
|
| Animals | 10 | 2025 | 19718 | 0.250 |
Why?
|
| Pyroptosis | 1 | 2025 | 31 | 0.230 |
Why?
|
| Caspase 8 | 1 | 2025 | 61 | 0.230 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2025 | 78 | 0.230 |
Why?
|
| Protein Isoforms | 2 | 2022 | 195 | 0.230 |
Why?
|
| Deoxyribonuclease I | 3 | 2012 | 38 | 0.220 |
Why?
|
| RNA Polymerase II | 1 | 2024 | 71 | 0.220 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2022 | 134 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2015 | 454 | 0.210 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 1 | 2022 | 4 | 0.210 |
Why?
|
| Friedreich Ataxia | 1 | 2022 | 4 | 0.210 |
Why?
|
| Cell Line | 8 | 2017 | 2015 | 0.210 |
Why?
|
| Chromosome Mapping | 2 | 2015 | 293 | 0.210 |
Why?
|
| RNA Splice Sites | 3 | 2018 | 22 | 0.200 |
Why?
|
| Alleles | 3 | 2014 | 422 | 0.200 |
Why?
|
| Mucopolysaccharidosis II | 1 | 2021 | 11 | 0.190 |
Why?
|
| Recombinational DNA Repair | 1 | 2021 | 20 | 0.190 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 388 | 0.190 |
Why?
|
| Tyrosinemias | 1 | 2021 | 19 | 0.190 |
Why?
|
| Transcription Factors | 6 | 2017 | 1459 | 0.190 |
Why?
|
| Cell Proliferation | 2 | 2022 | 942 | 0.190 |
Why?
|
| DNA, Mitochondrial | 3 | 2011 | 78 | 0.190 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2022 | 166 | 0.180 |
Why?
|
| Inflammation | 2 | 2025 | 1106 | 0.180 |
Why?
|
| Dendritic Cells | 2 | 2015 | 508 | 0.180 |
Why?
|
| Base Sequence | 2 | 2022 | 1311 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 4 | 2016 | 661 | 0.170 |
Why?
|
| Huntingtin Protein | 1 | 2019 | 138 | 0.150 |
Why?
|
| Gene Ontology | 1 | 2018 | 37 | 0.150 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 35 | 0.150 |
Why?
|
| Mutation | 3 | 2019 | 2461 | 0.150 |
Why?
|
| Sequence Analysis, DNA | 4 | 2012 | 397 | 0.140 |
Why?
|
| Central Nervous System | 1 | 2019 | 192 | 0.140 |
Why?
|
| Gene Editing | 1 | 2021 | 301 | 0.140 |
Why?
|
| Huntington Disease | 1 | 2018 | 146 | 0.140 |
Why?
|
| Species Specificity | 2 | 2014 | 335 | 0.130 |
Why?
|
| RNA, Small Interfering | 2 | 2019 | 856 | 0.130 |
Why?
|
| Phosphorylation | 1 | 2018 | 860 | 0.130 |
Why?
|
| Genetic Vectors | 1 | 2021 | 820 | 0.120 |
Why?
|
| Dependovirus | 1 | 2021 | 659 | 0.120 |
Why?
|
| HapMap Project | 2 | 2012 | 5 | 0.120 |
Why?
|
| DNA-Binding Proteins | 3 | 2022 | 1134 | 0.110 |
Why?
|
| Bacterial Infections | 1 | 2015 | 138 | 0.110 |
Why?
|
| Reproducibility of Results | 1 | 2018 | 1559 | 0.110 |
Why?
|
| Phenotype | 2 | 2015 | 1154 | 0.110 |
Why?
|
| Host-Pathogen Interactions | 1 | 2015 | 238 | 0.110 |
Why?
|
| RNA | 1 | 2016 | 404 | 0.100 |
Why?
|
| Neurons | 1 | 2018 | 860 | 0.100 |
Why?
|
| Proteins | 1 | 2018 | 742 | 0.100 |
Why?
|
| Pseudogenes | 1 | 2012 | 16 | 0.100 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 23 | 0.100 |
Why?
|
| Tuberculosis | 2 | 2015 | 267 | 0.100 |
Why?
|
| Gene Dosage | 1 | 2012 | 60 | 0.100 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2012 | 36 | 0.100 |
Why?
|
| DNA Footprinting | 1 | 2012 | 16 | 0.100 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 294 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2012 | 4 | 0.100 |
Why?
|
| Dual-Specificity Phosphatases | 1 | 2012 | 7 | 0.100 |
Why?
|
| Lymphocyte Count | 1 | 2012 | 70 | 0.100 |
Why?
|
| Epigenesis, Genetic | 2 | 2015 | 351 | 0.100 |
Why?
|
| Genetics, Population | 2 | 2009 | 41 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 101 | 0.090 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2015 | 388 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 678 | 0.090 |
Why?
|
| Nucleosomes | 1 | 2012 | 185 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 291 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2022 | 2100 | 0.080 |
Why?
|
| RNA Interference | 1 | 2012 | 593 | 0.080 |
Why?
|
| Population Dynamics | 1 | 2008 | 18 | 0.080 |
Why?
|
| Neoplasms | 1 | 2018 | 1258 | 0.080 |
Why?
|
| Binding Sites | 1 | 2010 | 870 | 0.070 |
Why?
|
| DNA | 1 | 2012 | 793 | 0.070 |
Why?
|
| Mice | 4 | 2025 | 10303 | 0.070 |
Why?
|
| Asthma | 1 | 2012 | 419 | 0.070 |
Why?
|
| Phylogeny | 1 | 2008 | 334 | 0.070 |
Why?
|
| Alagille Syndrome | 1 | 2006 | 1 | 0.070 |
Why?
|
| Receptor, Notch2 | 1 | 2006 | 8 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2012 | 621 | 0.070 |
Why?
|
| Statistics, Nonparametric | 2 | 2018 | 207 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2025 | 2890 | 0.060 |
Why?
|
| Yersinia Infections | 1 | 2025 | 9 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2018 | 106 | 0.060 |
Why?
|
| Disease Resistance | 1 | 2025 | 23 | 0.060 |
Why?
|
| Cell Death | 1 | 2025 | 272 | 0.050 |
Why?
|
| Iron-Binding Proteins | 1 | 2022 | 10 | 0.050 |
Why?
|
| CCCTC-Binding Factor | 1 | 2022 | 40 | 0.050 |
Why?
|
| Molecular Sequence Annotation | 2 | 2014 | 59 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2022 | 141 | 0.050 |
Why?
|
| Principal Component Analysis | 2 | 2014 | 60 | 0.050 |
Why?
|
| Software | 2 | 2018 | 371 | 0.050 |
Why?
|
| Cell Movement | 1 | 2022 | 424 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 386 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2025 | 1996 | 0.040 |
Why?
|
| Genotype | 2 | 2012 | 640 | 0.040 |
Why?
|
| Macrophages | 1 | 2025 | 1008 | 0.040 |
Why?
|
| Haplotypes | 2 | 2009 | 117 | 0.040 |
Why?
|
| Trinucleotide Repeat Expansion | 1 | 2018 | 33 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2018 | 21 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2018 | 155 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2025 | 3204 | 0.040 |
Why?
|
| Histones | 2 | 2011 | 463 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2018 | 528 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 290 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2018 | 379 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2015 | 20 | 0.030 |
Why?
|
| Cytosine | 1 | 2015 | 30 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2018 | 458 | 0.030 |
Why?
|
| Epigenomics | 1 | 2015 | 54 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 603 | 0.030 |
Why?
|
| Genetic Therapy | 1 | 2021 | 744 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 212 | 0.030 |
Why?
|
| Genes | 1 | 2014 | 96 | 0.030 |
Why?
|
| Female | 4 | 2021 | 31093 | 0.030 |
Why?
|
| Micrococcal Nuclease | 1 | 2012 | 12 | 0.030 |
Why?
|
| Male | 4 | 2021 | 27765 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2012 | 248 | 0.020 |
Why?
|
| Position-Specific Scoring Matrices | 1 | 2010 | 7 | 0.020 |
Why?
|
| DNA Cleavage | 1 | 2010 | 18 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 197 | 0.020 |
Why?
|
| Linear Models | 1 | 2012 | 423 | 0.020 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2012 | 229 | 0.020 |
Why?
|
| Data Mining | 1 | 2011 | 47 | 0.020 |
Why?
|
| Nigeria | 1 | 2010 | 8 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2010 | 28 | 0.020 |
Why?
|
| Gene Pool | 1 | 2009 | 1 | 0.020 |
Why?
|
| Senegal | 1 | 2009 | 2 | 0.020 |
Why?
|
| Chromosomes, Human, Y | 1 | 2009 | 5 | 0.020 |
Why?
|
| Philadelphia | 1 | 2009 | 16 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2010 | 145 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2010 | 166 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2009 | 121 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2009 | 129 | 0.020 |
Why?
|
| Russia | 1 | 2008 | 53 | 0.020 |
Why?
|
| Genome | 1 | 2010 | 253 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 251 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2008 | 577 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 968 | 0.020 |
Why?
|
| Protein Binding | 1 | 2010 | 1559 | 0.020 |
Why?
|
| Pedigree | 1 | 2006 | 191 | 0.020 |
Why?
|
| Adult | 1 | 2012 | 15879 | 0.010 |
Why?
|
| Middle Aged | 1 | 2012 | 16397 | 0.010 |
Why?
|